Merck partners for ‘blockbuster’ vaccine target
Themis obtains an exclusive licence from Merck to develop vaccine candidates with an undisclosed indication, using its measles virus vector-based platform.
Archives for August 26, 2019
SP Scientific partners with i-Dositecno, integrates its fill-finish offering
SP Scientific partners with Spanish i-Dositecno to offer complete aseptic vial and syringe fill-finish lines to clients in Europe and North America.
Scorpion venom provides clues for chronic pain and drug delivery
Researchers discover scorpion toxin that triggers pain through a previously unknown pathway, potentially opening up new avenues of investigation for treating chronic pain.